The Medical Affairs Company (TMAC) recognizes that not all programs are alike and customizes each program to the specific culture, therapeutic area, product lifecycle stage, and stakeholder needs of the client.
As a result of changing market dynamics, highlighted by the consistent demand from a variety of stakeholder groups for better quality, fair-balanced/evidence-based interactions, we have evolved our field-based model to also include the outsourcing of specialty MSL teams including Clinical Trial Liaisons (CTLs), Clinical Specialists (CSs), and Managed Markets Liaisons (MMLs)/Field-based Outcomes Research Managers (FORMs). Through our team of seasoned MSL Directors, we ensure that scientifically robust communications are delivered via compliant and appropriate exchanges across all programs.
The following Case Studies serve as examples of our success deploying customized Medical Science Liaison teams. While all examples are based on real client engagements, select details and specific therapeutic areas have been revised to prevent the dissemination of proprietary information.